Diagnosis and Treatment of Xerostomia (dry Mouth)

Overview

Journal Odontology

Specialty Dentistry

Date 2009 Jul 30

PMID 19639449

Citations 50

Authors

Joel J Napenas

Michael T Brennan

Philip C Fox

Affiliations

Soon will be listed here.

Abstract

Xerostomia (dry mouth) is a common complaint with widespread implications such as impaired quality of life, oral pain, and numerous oral complications. There are a variety of salivary and nonsalivary causes of xerostomia, the most frequent being medication side effects and systemic disorders. A systematic approach should be employed to determine the etiology of this condition, with distinctions made between patients with subjective complaints of xerostomia alone and those with measurable salivary gland dysfunction. Management is multidisciplinary and multimodal. This review summarizes the current literature on the etiology, diagnosis, and complications of xerostomia, and on the management of patients with xerostomia.

Citing Articles

The Oral Microbial Ecosystem in Age-Related Xerostomia: A Critical Review.

Pei X, Zhou L, Tsang M, Tai W, Wong S Int J Mol Sci. 2024; 25(23.

PMID: 39684528 PMC: 11640827. DOI: 10.3390/ijms252312815.

Oral Manifestations in Patients in Treatment with Antidepressants: A Systematic Review.

Alcazar-Hernandez J, Pecci-Lloret M, Guerrero-Girones J J Clin Med. 2024; 13(22).

PMID: 39598089 PMC: 11594724. DOI: 10.3390/jcm13226945.

Contribution of kelp dashi liquid to sustainable maintenance of taste sensation and promotion of healthy eating in older adults throughout the umami-taste salivary reflex.

Satoh-Kuriwada S, Gotoh S, Shoji N, Uneyama H, Komai M Front Nutr. 2024; 11:1406633.

PMID: 39257609 PMC: 11385619. DOI: 10.3389/fnut.2024.1406633.

Transdermal pilocarpine on the skin over salivary glands to increase salivation: an in vivo study.

Ishida N, Katsura A, Takagaki K, Arakawa H, Shimada T, Mizuno S BMC Oral Health. 2024; 24(1):881.

PMID: 39095752 PMC: 11297717. DOI: 10.1186/s12903-024-04667-y.

Association of Sleep Quality and General, Mental, and Oral Health with Lifestyle Traits (Dietary Intake, Smoking Status) in Arthritis: A Cross-Sectional Study from the Canadian Community Health Survey (CCHS).

Gheisary Z, Hoja I, Liu J, Papagerakis P, Weber L, Fenton M Nutrients. 2024; 16(13).

PMID: 38999838 PMC: 11243648. DOI: 10.3390/nu16132091.

References

Ship J, Pillemer S, Baum B . Xerostomia and the geriatric patient. J Am Geriatr Soc. 2002; 50(3):535-43. DOI: 10.1046/j.1532-5415.2002.50123.x. View

Ben-Aryeh H, Schiller M, Shasha S, Szargel R, GUTMAN D . Salivary composition in patients with essential hypertension and the effect of Pindolol. J Oral Med. 1981; 36(3):76-8. View

Croog S, Levine S, Testa M, Brown B, Bulpitt C, Jenkins C . The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986; 314(26):1657-64. DOI: 10.1056/NEJM198606263142602. View

Finkelstein M, Tanner M, Freedman M . Salivary and serum IgA levels in a geriatric outpatient population. J Clin Immunol. 1984; 4(2):85-91. DOI: 10.1007/BF00915040. View

Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R . Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002; 81(4):270-80. DOI: 10.1097/00005792-200207000-00003. View

Atkinson J, Wu A . Salivary gland dysfunction: causes, symptoms, treatment. J Am Dent Assoc. 1994; 125(4):409-16. DOI: 10.14219/jada.archive.1994.0059. View

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos H, Alexander E, Carsons S . Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002; 61(6):554-8. PMC: 1754137. DOI: 10.1136/ard.61.6.554. View

MANDEL I, Katz R . The effect of pharmacologic agents on salivary secretion and composition. II. Isoproterenol,alpha and beta adrenergic blockers. J Oral Ther Pharmacol. 1968; 4(4):260-9. View

Hamlar D, Schuller D, Gahbauer R, Buerki R, Staubus A, Hall J . Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma. Laryngoscope. 1996; 106(8):972-6. DOI: 10.1097/00005537-199608000-00011. View

10.

Baum B, Kousvelari E, Oppenheim F . Exocrine protein secretion from human parotid glands during aging: stable release of the acidic proline-rich proteins. J Gerontol. 1982; 37(4):392-5. DOI: 10.1093/geronj/37.4.392. View

11.

Scully C . Drug effects on salivary glands: dry mouth. Oral Dis. 2003; 9(4):165-76. DOI: 10.1034/j.1601-0825.2003.03967.x. View

12.

Thomson W, Chalmers J, Spencer A, Williams S . The Xerostomia Inventory: a multi-item approach to measuring dry mouth. Community Dent Health. 2000; 16(1):12-7. View

13.

Frydrych A, Davies G, Slack-Smith L, Heywood J . An investigation into the use of pilocarpine as a sialagogue in patients with radiation induced xerostomia. Aust Dent J. 2002; 47(3):249-53. DOI: 10.1111/j.1834-7819.2002.tb00337.x. View

14.

Helenius L, Meurman J, Helenius I, Kari K, Hietanen J, Suuronen R . Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol Scand. 2006; 63(5):284-93. DOI: 10.1080/00016350510020043. View

15.

Scott J, Bodner L, Baum B . Assessment of age-related changes in the submandibular and sublingual salivary glands of the rat using stereological analysis. Arch Oral Biol. 1986; 31(1):69-71. DOI: 10.1016/0003-9969(86)90116-0. View

16.

Nieuw Amerongen A, Veerman E . Saliva--the defender of the oral cavity. Oral Dis. 2002; 8(1):12-22. DOI: 10.1034/j.1601-0825.2002.1o816.x. View

17.

Fox P . Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy. Ann N Y Acad Sci. 2007; 1098:15-21. DOI: 10.1196/annals.1384.003. View

18.

Zbaren P, Ducommun J . Diagnosis of salivary gland disease using ultrasound and sialography: a comparison. Clin Otolaryngol Allied Sci. 1989; 14(3):189-97. DOI: 10.1111/j.1365-2273.1989.tb00360.x. View

19.

Baum B, Costa Jr P, Izutsu K . Sodium handling by aging human parotid glands is inconsistent with a two-stage secretion model. Am J Physiol. 1984; 246(1 Pt 2):R35-9. DOI: 10.1152/ajpregu.1984.246.1.R35. View

20.

Atkinson J, Shiroky J, Macynski A, Fox P . Effects of furosemide on the oral cavity. Gerodontology. 1989; 8(1):23-6. DOI: 10.1111/j.1741-2358.1989.tb00398.x. View